Abstract
The interaction of steroids with their nuclear receptors induces a cascade of regulatory events that results from the activation of specific sets of genes by the hormone/receptor complex1. Steroids, either acting alone or possibly synergistically with other growth factors, can influence the DNA synthesis and proliferation of specific target cells, initiate developmental pathways and activate expression of the differentiated phenotype2–7. Moreover, steroid hormones have been implicated in abnormal growth regulation both in tumours and tumour-derived cell lines8,9. The identification of complementary DNAs encoding the human glucocorticoid receptor (hGR) predicts two protein forms (α and β; 777 and 742 amino acids long, respectively) which differ at their carboxy termini10. We report here that both forms of the receptor are related, with respect to their domain structure, to the v-erb-A oncogene product of avian erythroblastosis virus (AEV), which suggests that steroid receptor genes and the c-erb-A proto-oncogene are derived from a common primordial regulatory gene. Therefore, oncogenicity by AEV may result, in part, from the inappropriate activity of a truncated steroid receptor or a related regulatory molecule encoded by v-erb-A. This suggests a mechanism by which transacting factors may facilitate transformation. We also identify a short region of hGR that is homologous with the Drosophila homoeotic proteins encoded by Antennapedia and fushi tarazu.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ringold, G. M. A. Rev. Pharmac. Tox. 25, 529–566 (1985).
Richards, G. & Ashburner, M. in Biochemical Regulation and Development Vol. 3B (eds Goldberger, R. & Yamamoto, K.) 213–253 (Plenum, New York, 1984).
Smith, L. D., Ecker, R. E. & Subtelny, S. Devl Biol. 17, 627–643 (1968).
Bardin, C. W., Bullock, L. P., Mills, N. C., Lin, Y.-C. & Jacob, S. in Receptors and Hormone Action Vol. 2 (eds O'Malley, B. W. & Birnbaumer, L.) 83–103 (Academic, New York, 1978).
Katzenellenbogen, B. S. A. Rev. Physiol. 42, 17–35 (1980).
Gorski, J. & Gannon, F. A. Rev. Physiol. 38, 425–450 (1976).
Arnold, A. P. & Gorski, R. A. A. Rev. Neurosci. 7, 413–442 (1984).
Lippman, M. in Breast Cancer: Trends in Research and Treatment (Raven, New York, 1975).
Lippman, M. E. & Bolan, G. Nature 256, 592–593 (1975).
Hollenberg, S. M. et al. Nature 318, 635–641 (1985).
Debuire, B. et al. Science 224, 1456–1459 (1984).
Feng, D. F., Johnson, M. S. & Doolittle, R. F. J. molec. Evol. 21, 112–125 (1985).
Doolittle, R. F. Science 214, 149–159 (1981).
Scott, M. P. & Weiner, A. J. Proc. natn. Acad. Sci. U.S.A. 81, 4115–4119 (1984).
Laughon, A. & Scott, M. P. Nature 310, 25–31 (1984).
McGinnis, W., Levine, M. S., Hafen, E., Kuroiwa, A. & Gehring, W. J. Nature 308, 428–433 (1984).
Poole, S. J., Kauvar, L. M., Drees, B. & Kornberg, T. Cell 40, 37–43 (1985).
Beachy, P. A., Helfand, S. L. & Hogness, D. S. Nature 313, 545–551 (1985).
White, R. A. H. & Wilcox, M. EMBO J. 4, 2035–2043 (1985).
Carlstedt-Duke, J., Okret, S., Wrange, O. & Gustafsson, J. A. Proc. natn. Acad. Sci. U.S.A. 79, 4260–4264 (1982).
Wrange, O., Okret, S., Radojcic, M., Carlstedt-Duke, J. & Gustafsson, J. A. J. biol. Chem. 259, 4534–4541 (1984).
Dellweg, H. G., Hotz, A., Mugele, K. & Gehring, U. EMBO J. 1, 285–289 (1982).
Sherman, M. R., Pickering, L. A., Rellwagen, F. M. & Miller, L. K. Fedn Proc. 37, 167–173 (1978).
Weinberger, C. et al. Science 228, 740–742 (1985).
Engelke, D. R., Ng, S.-Y., Shastry, B. & Roeder, R. G. Cell 19, 717–728 (1980).
Sakonju, S., Bogenhagen, D. F. & Brown, D. D. Cell 19, 13–25 (1980).
Bogenhagen, D. F., Sakonju, S. & Brown, D. D. Cell 19, 27–35 (1980).
Ginsberg, A. M., King, B. O. & Roeder, R. G. Cell 39, 479–489 (1984).
Miller, J., McLachlan, A. D. & Klug, A. EMBO J. 4, 1609–1614 (1985).
Jansson, M., Philipson, L. & Vennstrom, B. EMBO J. 2, 561–565 (1983).
King, C. R., Kraus, M. H. & Aaronson, S. A. Science 229, 974–976 (1985).
Schechter, A. L. et al. Science 229, 976–978 (1985).
Frykberg, L. et al. Cell 32, 227–238 (1983).
Yamamoto, T. et al. Cell 35, 71–78 (1983).
Sealy, L., Privalsky, M. L., Moscovici, G., Moscovici, C. & Bishop, J. M. Virology 130, 155–178 (1983).
Ullrich, A. et al. Nature 309, 418–425 (1984).
Lin, C. R. et al. Science 224, 843–848 (1984).
Xu, Y.-H. et al. Nature 309, 806–810 (1984).
Henry, C., Coquillaud, M., Saule, S., Stehelin, D. & Debuire, B. Virology 140, 179–182 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weinberger, C., Hollenberg, S., Rosenfeld, M. et al. Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product. Nature 318, 670–672 (1985). https://doi.org/10.1038/318670a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/318670a0
This article is cited by
-
Genomic effects of glucocorticoids
Protoplasma (2017)
-
Targeting liver X receptors in cancer therapeutics
Nature Reviews Cancer (2015)
-
Cloning, characterization and expression of estrogen receptor beta in the male half-smooth tongue sole, Cynoglossus semilaevis
Fish Physiology and Biochemistry (2013)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.